Aug 2026· Research· Vol 9· 0 citations· 47 references
Medicine
TL;DR
This study represents a paradigm shift from passive dural closure to active neuroimmunomodulation, offering a neuroprotective therapeutic strategy for traumatic brain injury through lymphatic-immune microenvironment engineering using rapamycin-eluting poly(l-lactide-co-ε-caprolactone) nanofibers.
Abstract
While current dural repair patches achieve mechanical sealing to prevent cerebrospinal fluid leakage, they fail to address the critical pathological cascades of traumatic brain injury, including structural disruption of meningeal lymphatic vessels and dysregulation of neuroimmune responses. Here, we break this therapeutic stalemate through lymphatic-immune microenvironment engineering using rapamycin-eluting poly(l-lactide-co-ε-caprolactone) nanofibers. This bioactive patch exerts its therapeutic effects through 3 mechanisms: (a) restoring immune homeostasis by modulating the T helper 17/regulatory T cell balance; (b) morphologically normalizing the meningeal lymphatic network; and (c) preventing cerebral tissue adhesion by suppressing fibroblasts proliferation. In rat traumatic brain injury models, 4% rapamycin-loaded poly(l-lactide-co-ε-caprolactone) nanofibers achieved much higher functional recovery and markedly reduced cerebral tissue loss compared to controls. Crucially, it reconstructed the immune microenvironment and normalized the morphology of the meningeal lymphatic system. This study represents a paradigm shift from passive dural closure to active neuroimmunomodulation, offering a neuroprotective therapeutic strategy for traumatic brain injury.
Spinal cord injury (SCI) triggers a complex secondary injury cascade characterized by oligodendrocyte (OL) death and axonal demyelination, leading to permanent neurological deficits. Despite the presence of endogenous oligodendrocyte progenitor cells (OPCs), the inhibitory microenvironment-marked by inflammation, glial...
E. Petillo, V. Veneruso, E. Frigerio et al.· Advances in Materials· 0 citations
In a rat model of spinal cord injury, Exos‐EA@CS/HA‐Gel restored the function of the barrier between blood and spinal cord, promoting tissue repair and suggest that Exos‐EA@CS/HA‐Gel may be effective against spinal cord injury.
Xiao-Ling Zhou, Yan Lin, Rong-Qiu Wang et al.· Advanced Healthcare Material...· 0 citations
Repairing peripheral nerve injuries remains challenging because it requires biomaterials that can simultaneously modulate the adverse immune microenvironment and provide a bionic niche with integrated physical and biochemical cues. To address this, we developed a porcine sciatic nerve-derived acellular matrix membrane...
Xiu-Yan Gao, Kun Liu, Yong-Bin Gao et al.· Biomaterials Advances· 0 citations
Peripheral nerve injuries often result in incomplete functional recovery, despite technically successful microsurgical repair. Traditional strategies focus on structural continuity but neglect the immunobiological environment critical for regeneration. CCL2 (monocyte chemoattractant protein-1, MCP-1), a chemokine that...
Claudy Sarpong, Sumaia G. Khoury, K. Bangayan et al.· Annals of Plastic Surgery· 0 citations
Spinal cord injury (SCI) is a severe traumatic disorder of the central nervous system that results in substantial motor and sensory dysfunction. The hostile post-injury microenvironment, marked by excessive oxidative stress, inflammatory responses, and progressive neuronal degeneration, greatly limits neural repair. In...
Xing-Yu Zhu, Zhong-Hua Liu, Ke-Wei Li et al.· Advanced Healthcare Material...· 0 citations
This work identifies pericytes as a central regulatory node and establishes a pericyte-targeted PDC nanoplatform for durable MS treatment, highlighting its translational potential as a complementary strategy to conventional immunomodulatory approaches.